Navigation Links
Henry Gabelnick receives lifetime achievement award
Date:5/27/2010

Arlington, VA (May 27, 2010) -- CONRAD is pleased to announce that Executive Director, Henry Gabelnick, Ph.D, was awarded the lifetime achievement award at the 6th International Microbicides 2010 Conference. This year's conference, Building Bridges to HIV Prevention, was held in Pittsburgh, Pennsylvania May 22-25 and before an audience of more than 1,000 HIV advocates and scientists, Dr. Gabelnick was recognized for his unparalleled commitment and dedication to the development of microbicides. The lifetime achievement award was his second in 2005, Dr. Gabelnick was recognized by the International Conference on AIDS India for a lifetime devoted to reproductive health.

"In a field with so many dedicated, brilliant and persistent researchers, I am tremendously honored to be singled out by my peers," said Dr. Gabelnick. His acceptance speech described his early years working in the chemical industry, specifically in the field of plastics, and his journey to more fulfilling work in the field of contraception and microbicides. Dr. Gabelnick received his undergraduate and graduate degrees at MIT and his doctorate from Princeton. After beginning his career in the chemical industry, Dr. Gabelnick moved to the Biomedical Engineering Branch of the National Institutes of Health. He joined CONRAD at its inception in 1986, and focused primarily on developing new methods of contraception until it became clear that HIV prevention was crucial to overall reproductive health. For the past 20 years, CONRAD has contributed to the microbicide development field through the development of preclinical algorithms and primate models, standardization of colposcopy techniques, biomarker research and clinical trials.

CONRAD scientists also presented the following study findings and analyses at various sessions during the conference:

  • Christine Mauck, M.D., M.P.H. - Assessing Markers of Inflammation after Vaginal Product Use: Nonoxynol-9, Cellulose Sulfate, and HEC Placebo Comparative Double-Blind Phase I Trial and Colposcopy: Still Useful in Microbicide Safety Trials?
  • Gustavo Doncel, M.D., Ph.D. - Combining HIV Prevention and Contraception Technologies
  • Mohammed Saifuddin, D.V.M., Ph.D. - Evaluation of 6% Cellulose Sulfate and 0.5% PRO2000 Gel Microbicide Efficacy in a Single-Dose Intravaginal R5+X4 SHIV Infection Model in Rhesus Macaques Pre-treated with Depo-Provera
  • Irina Zalenskaya, Ph.D. - Gene Expression Profile of Vaginal Epithelial Cells Exposed to Proinflammatory Agents - Identification of Novel Biomarkers of Mucosal Safety
  • Jill Schwartz, M.D. - Pilot Clinical Pharmacokinetic and Pharmacodynamic Study of UC781 Vaginal Gel


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Henry Ford Hospital study: Fewer infections with new heart-pump implant
2. Henry Ford Hospital: New left-side heart pump improves right-side heart function
3. Henry Ford Hospital study: Less prep needed for colonoscopy
4. Henry Ford Health System goes radical: Creating the hospital of the future
5. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
6. Henry Ford Hospital study: Shoulder function not fully restored after surgery
7. Henry Ford Hospital study shows link between vitamin D, skin cancer
8. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
9. National Press Club to Host NEWSMAKER Media Briefing on Cornhusker Kickback With South Carolina Attorney General Henry McMaster
10. iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems
11. Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments because ... Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three ... more sedation methods may be recommended based on the severity of the anxiety experienced ...
(Date:5/22/2017)... ... 2017 , ... “Homeostasis: The Journey of a Manic-Depressive” tells the story in ... Rodriguez takes readers on a rollercoaster ride that includes a midnight trek to the ... a dark place where Donald considers suicide. Readers learn how Donald finally achieves ...
(Date:5/22/2017)... ... May 22, 2017 , ... OSF Ventures, ... investing in InsightRX, an early stage company in San Francisco that has developed ... Greatpoint Ventures Innovation Fund acted as the lead investor in the ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... ... styled corporate text designs created specifically for use in Final Cut Pro X. ... for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver a professional ...
(Date:5/21/2017)... ... , ... For more than 20 years United Cutlery has been distinguished by ... from functional to fantasy. United Cutlery has always been “Stronger. Sharper” than the competition ... , Offering a range of weapons and tools built for battle, the M48 line ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) ... second quarter ended April 1, 2017 .   GAAP ... compared to the prior year period as the sale ... gain, while non-GAAP diluted EPS of $0.50 increased 6.4%.  ... constant currency terms.  Excluding the effects of blood screening ...
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
Breaking Medicine Technology: